CEBPD and asthma: Our most recent study found that CEBPD had the largest difference in glucocorticoid-induced expression changes in ASM from non-asthma donors versus fatal asthma donors (log2 fold change of 1.43 versus 0.48 with budesonide exposure) [20], suggesting that differing levels of CEBPD expression may influence glucocorticoid responsiveness in people with asthma.